MicroRNA Biomarkers in Canine Diffuse Large B-Cell Lymphoma

Area of Science:

• Veterinary Oncology
• Molecular Diagnostics
• Gene Expression Analysis

Background:

• Diffuse large B-cell lymphoma (DLBCL) is a common canine cancer.
• Current DLBCL diagnosis involves cytology, immunophenotyping, histopathology, and immunohistochemistry.
• MicroRNAs (miRNAs) are key gene regulators implicated in cancer, showing potential as stable biomarkers.

Purpose of the Study:

• To identify specific miRNA expression patterns (signatures) in canine DLBCL.
• To evaluate the potential of these miRNA signatures as ancillary molecular diagnostic tools for DLBCL in dogs.

Main Methods:

• miRNA was extracted from formalin-fixed, paraffin-embedded lymph node tissues of 22 DLBCL cases and 14 nonneoplastic controls.
• Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was used to measure the relative gene expression of 8 tumor-regulating miRNAs.
• Statistical analysis was performed to assess the diagnostic accuracy of identified miRNA signatures.

Main Results:

• Downregulation of the let-7 miRNA family and miR-155 was observed in DLBCL.
• Upregulation of miR-34a was detected in DLBCL compared to control tissues.
• Combinations of miR-34a/let-7f or let-7b/let-7f achieved 100% differentiation between DLBCL and controls.
• let-7f alone demonstrated 97% accuracy in discriminating DLBCL from nonneoplastic tissue.

Conclusions:

• Specific miRNA expression profiles can serve as reliable biomarkers for canine DLBCL.
• The identified miRNA signatures, particularly let-7f, offer potential for developing rapid and accurate ancillary diagnostic tests.
• This research advances the development of molecular tools for improved canine lymphoma diagnosis.